Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
MET overexpression
Cancer:
Hepatocellular Cancer
Drug:
WXSH0011
(
FGFR inhibitor
,
c-MET inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
ASCO 2020
Title:
Preclinical evaluation of WXSH0011, a selective small molecule dual inhibitor of FGFR/c-Met.
Published date:
05/28/2020
Excerpt:
WXSH0011 inhibited cell proliferation in...c-Met overexpressed MHCC97H and EBC-1 cell line with IC50 0.832 µM, 0.52 µM,…
DOI:
10.1200/JCO.2020.38.15_suppl.e15641
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login